一分钟看懂
这是一项关于小细胞肺癌的III 期研究，登记的药物或干预包括BL-M14D1 and Atezolizumab；Carboplatin+ Etoposide + Atezolizumab followed by Atezolizumab and Lurbinectedin，当前状态为招募中。登记地点显示中国Springdale、Glendale、Long Beach、Los Angeles等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
BL-M14D1 and Atezolizumab；Carboplatin+ Etoposide + Atezolizumab followed by Atezolizumab and Lurbinectedin · III 期
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- Highlands Oncology Group · Springdale
- Los Alamitos Hematology/Oncology Medical Group · Glendale
- MemorialCare Todd Cancer Institute · Long Beach
- Valkyrie Clinical Trials · Los Angeles
- Total Health and Research Center · Miami
- Astera Cancer Care · East Brunswick
- Virginia Cancer Specialists · Fairfax
- Canberra Hospital · Garran
- Tasman Oncology · Southport
- Flinders Medical Centre · Bedford Park
- MHAT Dr. Tota Venkova · Gabrovo
- MHAT Heart and Brain · Pleven
- Medical Centre FutureMeds · Plovdiv
- MHAT Pulmed · Plovdiv
- UMHAT Sveti Ivan Rilski · Sofia
- MHAT Serdikamed · Sofia
- Arthur Child Cancer Centre · Calgary
- University of Sherbrooke · Greenfield Park
- Nemocnice České Budějovice, a.s. · České Budějovice
- Nemocnice Agel Vítkovice · Ostrava
- Fakultní nemocnice Ostrava (FN Ostrava) · Ostrava-Poruba
- Organization Centre Hospitalier Intercommunal de Creteil (CHIC) - Centre de Recherche Clinique (CRC) (Clinical Research Center) · Créteil
- CLB - Centre Léon Bérard · Lyon
- IPC - lnstitut Paoli-Calmettes · Marseille
- Universite Pierre et Marie Curie (UPMC) - Center de Recherche des Cordeliers (CRC) · Paris
- ICO - L'Institut de Cancérologie de L'Ouest · Saint-Herblain
- LTD High Technology Hospital Medcenter · Tbilisi
- Ltd New Hospitals · Tbilisi
- Pineo Medical Ecosystem LtD · Tbilisi
- LLC Todua Clinic · Tbilisi
公开的入选条件
- * Histologically or cytologically confirmed first-line (1L), extensive-stage (ES) small cell lung cancer (SCLC)
- * Must be eligible to receive a platinum-based chemotherapy regimen in combination with an anti-PD-L1 inhibitor.
- * At least one measurable lesion based on RECIST v1.1 per investigator assessment.
- * An Eastern Cooperative Oncology Group performance status (ECOG PS) of 0 to 1.
- * Adequate organ function
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT07625644；登记信息更新于 2026-09-17。